Tilak Mandadi insider trades: CVS HEALTH (CVS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Tilak reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 8, 2026 | CVS | ↓ Sell | 69,551 | $89.58 | $6.2M | Direct | May 11, 2026 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CVS insiders
Open-market trades in the last 12 months
About Tilak Mandadi's insider trades
Tilak Mandadi is EVP, Chief Exp & Tech Officer at CVS HEALTH (CVS). Since May 8, 2026, Tilak has reported no open-market purchases and 1 sale worth $6.2M on SEC Form 4. In the last 12 months: 1 sale ($6.2M).
Their filings also include grants and awards (13 filings), shares withheld for taxes (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CVS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.